Skip to main content

Day: June 30, 2023

Listing as Global InterConnection Group as of 7 July 2023

DISRUPTIVE CAPITAL ACQUISITION COMPANY LIMITED(“DCAC” or the “Company”) in respect ofDCAC Shareholders (ISIN Code GG00BMB5XZ39) and DCAC Public Warrant Holders (ISIN Code GG00BMB5XY22) Listing as Global InterConnection Group as of 7 July 2023 30 June 2023 Please refer to the attached press release. Attachment20230630 DCAC-Global InterConnection Group Press Release – final version

Continue reading

Milk 2.0: Plant-based Milk Market Set to Soar Past USD 123.1 Billion by 2030

The global Plant-based Milk market size is expected to reach USD 123.1 billion by 2030 and exhibit a CAGR of 15% in the forecast period (2023−2030), according to Skyquest’s latest research report. The growing health consciousness, increasing lactose intolerance and dairy allergies, and rising vegan and vegetarian population are fueling the market’s growth. Westford, USA, June 30, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Plant-based Milk market, the rising variety of plant-based milk alternatives, increasing investment in research and development, expanding distribution channels, product innovation and flavors, strategic partnerships and collaborations, growing consumer awareness and education, shifting consumer preferences towards sustainable and ethical products, improved...

Continue reading

Logent Group acquires Logistikas and strengthens its position as one of the contract logistics leaders in the Nordics.

Logent Group has today entered into an agreement with KH Group to acquire all shares in the Finnish company Logistikas Oy (“Logistikas”). The debt-free purchase price of the share transaction is EUR 23.5 million and the total purchase price paid to the sellers for the shares and other equity items is approximately EUR 18.5 million. In 2022, Logistikas’ net sales amounted to EUR 31.8 million and EBITDA to EUR 2.4 million. The acquisition is not subject to any conditions and the closing takes effect immediately. Logistikas has a strong reputation and a solid client base in contract logistics, including both dedicated solutions, a complementary multi-client warehousing offering and transport management services. Being present in the western and central parts of Finland, Logistikas is strategically positioned for further growth and will be...

Continue reading

Inside information: KH Group sells the logistics service company Logistikas

KH Group PlcInside information 30 June 2023 at 5:30 pm EEST Inside information: KH Group sells the logistics service company Logistikas As part of its strategic transformation, KH Group Plc has today, on 30 June 2023, together with the other shareholders of Logistikas Oy, sold the shares of Logistikas Oy to the Swedish logistics company Logent AB. The transaction was signed and completed simultaneously. The debt-free purchase price of the share transaction is EUR 23.5 million. KH Group’s holding in Logistikas was 66.5% and its share of the purchase price, after the deduction of net debt and transaction costs, is approximately EUR 11.9 million, including the purchase price for the shares and for the receivables from Logistikas Oy related to dividend and capital distribution in conjunction with the transaction. The final purchase price will...

Continue reading

Carbon Nanotube Market to Worth USD 97.64 Billion by 2030 | Skyquest Technology

Westford, June 30, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, carbon nanotubes (CNTs) have emerged as a highly desirable material for a wide range of applications that demand exceptional properties surpassing those of conventional materials. Their unique combination of high strength, electrical conductivity, durability, lightweight nature, and thermal conductivity makes them a preferred choice in numerous industries. Browse in-depth TOC on the “Carbon Nanotube Market.”Pages – 229 Tables – 91 Figures –76Carbon nanotubes (CNTs) are fascinating one-dimensional structures composed of rolled-up sheets of graphene, a two-dimensional carbon lattice. The discovery of CNTs has ignited tremendous research interest due to their extraordinary properties and the endless possibilities they offer for various applications....

Continue reading

The First of Long Island Corporation Announces Second Quarter Cash Dividend of $.21 Per Share

MELVILLE, N.Y., June 30, 2023 (GLOBE NEWSWIRE) — The First of Long Island Corporation (Nasdaq: FLIC) announced today the declaration of a second quarter cash dividend in the amount of $.21 per share. This represents a 5.0% increase over the dividend of $.20 per share declared in the same quarter last year. The dividend will be paid on July 20, 2023 to shareholders of record on July 12, 2023. The First of Long Island Corporation is the parent company of The First National Bank of Long Island. Through its branch network branded as First National Bank LI, the Bank focuses on business and consumer needs on Long Island and in New York City. We offer a broad set of lending, deposit, investment, and digital products. First National Bank LI is known for its culture of delivering extraordinary service and a “Customer First” banking experience...

Continue reading

Transforming Processes, Amplifying Results: Intelligent Process Automation Market Set to Soar Past USD 43.53 Billion by 2030

The global Intelligent Process Automation market size is expected to reach USD 43.53 billion by 2030 and exhibit a CAGR of 13.8% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing demand for operational efficiency and cost savings, advancements in artificial intelligence and machine learning technologies, and rising adoption of automation in various industries are fueling the market’s growth. Westford, USA, June 30, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Intelligent Process Automation market, increased adoption of robotic process automation (RPA), integration of artificial intelligence and machine learning capabilities, the emergence of low-code or no-code automation platforms, focus on hyper-automation for end-to-end process...

Continue reading

Pasithea Therapeutics Confirms Previous Creation of Independent Special Committee of its Board of Directors

Special Committee Continues to Actively Evaluate Unsolicited Proposal from Lucy Scientific Discovery Inc. PALO ALTO, Calif. and MIAMI, June 30, 2023 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research, and development of innovative treatments for central nervous system (CNS) disorders, confirms its Board of Directors (“Board”) has previously formed a special committee of independent and disinterested directors (the “Special Committee”) to assess an unsolicited proposal from Lucy Scientific Discovery Inc. (NASDAQ: LSDI) (“Lucy”) to acquire all outstanding shares of Pasithea common stock for per share consideration consisting of $0.60 in cash plus $0.25 worth of Lucy common stock. Consistent with its fiduciary obligations...

Continue reading

SciSparc Receives Approval to Conduct Phase IIb Clinical Trial for SCI-110 to Treat Tourette Syndrome in Germany

The Federal Institute for Drugs and Medical Devices in Germany granted the Company approval to use SCI-110 in a clinical trial at the Hannover Medical School TEL AVIV, Israel, June 30, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced it has been granted an approval from the Federal Institute for Drugs and Medical Devices in Germany (“BfArM”) for its Phase IIb clinical trial to use SCI-110 for treating adults with Tourette Syndrome (“TS”) at the Hannover Medical School in Hannover, Germany. The Phase IIb clinical trial will be conducted at three global leading centers of excellence: the Yale Child Study Center...

Continue reading

Capricor Therapeutics Announces Positive 24-Month Results from Ongoing HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy

-Improvements in Left Ventricular Ejection Fraction (LVEF) for the Majority of Patients Suggest Preservation of Cardiac Function- -Results in Performance of the Upper Limb PUL v2.0 Continue to Show Long-Term Benefit in Skeletal Muscle Function (p=0.02)- -Safety and Efficacy Results Continue to Suggest Potential Disease Attenuation in Duchenne Muscular Dystrophy (DMD)- -Results to be Presented at the PPMD Annual Conference Being Held Today- SAN DIEGO, June 30, 2023 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, today announced positive 24-month safety and efficacy results from its ongoing HOPE-2 open label extension (OLE) study with its lead asset,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.